DR Horton Inc (DHI)

Currency in USD
144.20
-1.05(-0.72%)
Closed·
145.00+0.80(+0.55%)
·
Earnings results expected in 6 days
DHI is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
142.79144.78
52 wk Range
114.17184.55
Key Statistics
Prev. Close
145.25
Open
144.48
Day's Range
142.79-144.78
52 wk Range
114.17-184.55
Volume
1.8M
Average Vol. (3m)
2.91M
1-Year Change
20.3572%
Book Value / Share
82.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DHI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
155.64
Upside
+7.94%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 12 consecutive years

DR Horton Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

D.R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 126 markets across 36 states under the names of D.R. Horton. The company also constructs and sells single-family detached homes; and attached homes, such as townhomes and duplexes. In addition, it provides mortgage financing and title agency services; and engages in the residential lot development business. Further, the company develops, constructs, owns, leases, and sells multi-family and single-family rental properties; conducts insurance-related operations; and owns water rights and other water-related assets, as well as non-residential real estate, including ranch land and improvements. It primarily serves homebuyers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Arlington, Texas.

DR Horton Inc SWOT Analysis


Strategic Advantage
Delve into how America's largest homebuilder leverages its scale, $6.6 billion liquidity position, and aggressive $2.5 billion share repurchase program to outperform competitors during market volatility.
Analyst Perspectives
Price targets range dramatically from $105 to $180, reflecting divided sentiment on DHI's premium valuation of 1.7x forward book value versus industry average of 1x.
Financial Outlook
Projected FY26 revenue of $33.5-35 billion with 86,000-88,000 home closings, while maintaining a solid 14% ROE despite market headwinds and margin pressures.
Market Challenges
D.R. Horton navigates housing affordability constraints with resilient operational strategies despite recent earnings volatility and uneven demand in a structurally underbuilt market.
Read full SWOT analysis

DR Horton Inc Earnings Call Summary for Q1/2026

  • D.R. Horton reported Q1 2026 EPS of $2.03 (beating $1.93 forecast) and revenue of $6.9 billion (exceeding expectations by 4.7%), though stock fell 3.2% pre-market despite the earnings beat.
  • Home sales revenue declined to $6.5 billion from $7.1 billion YoY, with 17,818 homes closed (down from 19,059) at an average price of $365,500 (3% decrease), reflecting affordability constraints.
  • The company issued Q2 guidance of $7.3-7.8 billion in revenue with 19,700-20,200 home closings, and FY2026 projections of $33.5-35 billion with 86,000-88,000 closings.
  • Management plans to return capital to shareholders through approximately $2.5 billion in stock repurchases and $500 million in dividends for fiscal 2026.
  • CEO Paul Romanowski emphasized capital efficiency and noted continuing demand from first-time homebuyers despite market challenges including affordability issues and cautious consumer sentiment.
Last Updated: 01/20/2026, 10:00 AM
Read Full Transcript
DR Horton investor slides for Q1/2026
D.R. Horton Q1 2026 presentation
Last Update: Jan 20, 2026
See full investor slides

Compare DHI to Peers and Sector

Metrics to compare
DHI
Peers
Sector
Relationship
P/E Ratio
12.6x11.2x10.8x
PEG Ratio
−0.57−0.180.02
Price / Book
1.8x2.1x1.4x
Price / LTM Sales
1.3x0.9x0.9x
Upside (Analyst Target)
7.7%−20.1%28.7%
Fair Value Upside
Unlock21.7%10.8%Unlock

Analyst Ratings

5 Buy
14 Hold
2 Sell
Ratings:
21 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 155.64
(+7.94% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Hold147.00+1.94%155.00MaintainApr 08, 2026
Barclays
Hold128.00-11.23%129.00MaintainApr 08, 2026
Seaport Global Securities
Hold---DowngradeApr 06, 2026
UBS
Buy193.00+33.84%193.00MaintainMar 12, 2026
Truist Securities
Hold155.00+7.49%-New CoverageMar 03, 2026

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 11.07%
Dividend Yield
1.25%
Industry Median 2.08%
Annualized Payout
1.80
Paid quarterly
5-Years Growth
+17.88%
Growth Streak

Earnings

Latest Release
Jan 20, 2026
EPS / Forecast
2.03 / 1.93
Revenue / Forecast
6.9B / 6.59B
EPS Revisions
Last 90 days

DHI Income Statement

People Also Watch

364.96
TER
-0.15%
61.28
FISV
+3.83%
389.72
INTU
+6.25%
239.32
ADSK
+4.69%

FAQ

What Is the DR Horton (DHI) Stock Price Today?

The DR Horton stock price today is 144.20 USD.

What Stock Exchange Does DR Horton Trade On?

DR Horton is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for DR Horton?

The stock symbol for DR Horton is "DHI."

Does DR Horton Pay Dividends? What’s The Current Dividend Yield?

The DR Horton dividend yield is 1.25%.

What Is the DR Horton Market Cap?

As of today, DR Horton market cap is 41.77B USD.

What Is DR Horton's Earnings Per Share (TTM)?

The DR Horton EPS (TTM) is 11.07.

When Is the Next DR Horton Earnings Date?

DR Horton will release its next earnings report on Apr 21, 2026.

From a Technical Analysis Perspective, Is DHI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has DR Horton Stock Split?

DR Horton has split 10 times.

How Many Employees Does DR Horton Have?

DR Horton has 14341 employees.

What is the current trading status of DR Horton (DHI)?

As of Apr 15, 2026, DR Horton (DHI) is trading at a price of 144.20 USD, with a previous close of 145.25 USD. The stock has fluctuated within a day range of 142.79 USD to 144.78 USD, while its 52-week range spans from 114.17 USD to 184.55 USD.

What Is DR Horton (DHI) Price Target According to Analysts?

The average 12-month price target for DR Horton is 155.64 USD, with a high estimate of 193 USD and a low estimate of 117 USD. 5 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +7.94% Upside potential.

What Is the DHI Premarket Price?

DHI's last pre-market stock price is 144.50 USD. The pre-market share volume is 2,220.00, and the stock has decreased by -0.75, or -0.52%.

What Is the DHI After Hours Price?

DHI's last after hours stock price is 145.00 USD, the stock has decreased by 0.80, or 0.55%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.